Atara Biotherapeutics (ATRA) EBT Growth (1y) (2014 - 2026)
Atara Biotherapeutics (ATRA) EBT Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,140.26% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 88.57% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | -110.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -110.91% |
| Dec 31, 2025 | 73.35% |
| Sep 30, 2025 | 80.50% |
| Jun 30, 2025 | 112.55% |
| Mar 31, 2025 | 219.80% |
| Dec 31, 2024 | 78.97% |
| Sep 30, 2024 | 68.59% |
| Jun 30, 2024 | 73.21% |
| Mar 31, 2024 | 57.55% |
| Dec 31, 2023 | 18.95% |
| Sep 30, 2023 | 16.97% |
| Jun 30, 2023 | -485.07% |
| Mar 31, 2023 | 15.16% |
| Dec 31, 2022 | 20.27% |
| Sep 30, 2022 | 0.69% |
| Jun 30, 2022 | 122.04% |
| Mar 31, 2022 | -12.47% |
| Dec 31, 2021 | -15.04% |
| Sep 30, 2021 | -13.88% |
| Jun 30, 2021 | -8.16% |